Recent studies have found that disabling MKNK2 could protect against diet-induced obesity, which might result from greater ATP consumption, mitochondrial oxidative metabolism, and other energy utilization processes [51]. Here, MKNK2 is linked to obesity due to melanocortin 4 receptor deficiency.